These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10587280)

  • 21. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
    Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
    Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Benzodiazepine withdrawal with carbamazepine].
    Kaendler SH; Volk S; Pflug B
    Nervenarzt; 1996 May; 67(5):381-6. PubMed ID: 9005346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Panic disorder: guidelines to safe use of benzodiazepines.
    Garvey MJ
    Geriatrics; 1993 Jul; 48(7):49-53, 56-8. PubMed ID: 8100794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment methods for discontinuation of long-term benzodiazepine use].
    Oude Voshaar RC; Gorgels WJ; Mol AJ; Couvée JE; van Balkom AJ; Zitman FG
    Ned Tijdschr Geneeskd; 2001 Jul; 145(28):1347-50. PubMed ID: 11484431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medication discontinuation in panic disorder.
    Ballenger JC; Pecknold J; Rickels K; Sellers EM
    J Clin Psychiatry; 1993 Oct; 54 Suppl():15-21; discussion 22-4. PubMed ID: 8262887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzodiazepine treatment of panic and agoraphobic symptoms: use, dependence, toxicity, abuse.
    Salzman C
    J Psychiatr Res; 1993; 27 Suppl 1():97-110. PubMed ID: 7908335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of long-term benzodiazepine abstinence in participants of a randomized controlled benzodiazepine withdrawal program.
    Voshaar RC; Gorgels WJ; Mol AJ; van Balkom AJ; Mulder J; van de Lisdonk EH; Breteler MH; Zitman FG
    Can J Psychiatry; 2006 Jun; 51(7):445-52. PubMed ID: 16838826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder.
    Bruce TJ; Spiegel DA; Gregg SF; Nuzzarello A
    Am J Psychiatry; 1995 Aug; 152(8):1156-60. PubMed ID: 7625463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The treatment of benzodiazepine dependence.
    Ashton H
    Addiction; 1994 Nov; 89(11):1535-41. PubMed ID: 7841868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzodiazepine use, cognitive impairment, and cognitive-behavioral therapy for anxiety disorders: issues in the treatment of a patient in need.
    Otto MW; Bruce SE; Deckersbach T
    J Clin Psychiatry; 2005; 66 Suppl 2():34-8. PubMed ID: 15762818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies for discontinuing long-term benzodiazepine use: meta-analysis.
    Voshaar RC; Couvée JE; van Balkom AJ; Mulder PG; Zitman FG
    Br J Psychiatry; 2006 Sep; 189():213-20. PubMed ID: 16946355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. International Study of Expert Judgement on Therapeutic Use of Benzodiazepines and Other Psychotherapeutic Medications: V. Treatment strategies in panic disorder, 1992-1997.
    Uhlenhuth EH; Balter MB; Ban TA; Yang K
    J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):27S-31S. PubMed ID: 9872710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of benzodiazepine dependence].
    Soyka M; München B
    Fortschr Neurol Psychiatr; 2019 Apr; 87(4):259-270. PubMed ID: 30999380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thinking about stopping treatment for panic disorder.
    DuPont RL
    J Clin Psychiatry; 1990 Dec; 51 Suppl A():38-45. PubMed ID: 2258376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder.
    Roy-Byrne P; Russo J; Pollack M; Stewart R; Bystrisky A; Bell J; Rosenbaum J; Corrigan MH; Stolk J; Rush AJ; Ballenger J
    Psychol Med; 2003 Apr; 33(3):511-8. PubMed ID: 12701671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to face a patient with benzodiazepine dependence in primary health care? Strategies for withdrawal.
    Aguiluz J; Álvarez M; Pimentel E; Abarca C; Moore P
    Medwave; 2018 Jan; 18(1):e7159. PubMed ID: 29385122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Withdrawal from long-term benzodiazepine use: randomised trial in family practice.
    Vicens C; Fiol F; Llobera J; Campoamor F; Mateu C; Alegret S; Socías I
    Br J Gen Pract; 2006 Dec; 56(533):958-63. PubMed ID: 17132385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term drug treatment of panic disorder.
    Burrows GD; Judd FK; Norman TR
    J Psychiatr Res; 1993; 27 Suppl 1():111-25. PubMed ID: 7908330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis.
    Parr JM; Kavanagh DJ; Cahill L; Mitchell G; McD Young R
    Addiction; 2009 Jan; 104(1):13-24. PubMed ID: 18983627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.
    Mercier-Guyon C; Chabannes JP; Saviuc P
    Curr Med Res Opin; 2004 Sep; 20(9):1347-55. PubMed ID: 15383182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.